NVS (Novartis AG) Other Current Receivables : $129 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Other Current Receivables?

Novartis AG's Other Current Receivables for the quarter that ended in Mar. 2025 was $129 Mil.

Novartis AG's quarterly Other Current Receivables increased from Sep. 2024 ($184.00 Mil) to Dec. 2024 ($2,116.00 Mil) but then stayed the same from Dec. 2024 ($2,116.00 Mil) to Mar. 2025 ($129.00 Mil).

Novartis AG's annual Other Current Receivables increased from Dec. 2022 ($1,828.00 Mil) to Dec. 2023 ($2,269.00 Mil) but then declined from Dec. 2023 ($2,269.00 Mil) to Dec. 2024 ($2,116.00 Mil).

Novartis AG Other Current Receivables Historical Data

The historical data trend for Novartis AG's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Current Receivables Chart

Novartis AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

1,819.00

1,616.00

1,828.00

2,269.00

2,116.00

Novartis AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Receivables	Get a 7-Day Free Trial															411.00	252.00	184.00	2,116.00	129.00

Novartis AG Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Novartis AG Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Novartis AG's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NOVN:Mexico NVS N:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOT0:Germany NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.